Evaluation of FPT-20 for the Treatment of Spermatogenesis and Semen Disorders
Key facts
- Who runs it
- Trieu, Nguyen Thi, M.D.
- Where
- Vietnam1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 16 people enrolled
- Started
- 29 Oct 2020
- Ended
- 20 May 2026
- Type of study
- Interventional
- Treatments tested
- FPT-20
- Record updated
- 8 June 2026
Who can take part
- Age
- 25 years to 40 years
- Sex
- Men only
- Healthy volunteers
- Can take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- The selected person has evidence of spermatogenesis disorder, no sperm, and weak sperm that do not meet the standards in terms of quantity and quality
- There are signs of orchitis
- Accepting patients with other comorbidities such as metabolic diseases, congenital or acquired immunodeficiency, HIV/AIDS, HBV, HCV, and Tuberculosis
Who cannot take part
- Do not select patients with advanced cancer
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This clinical study aims to evaluate the efficacy and safety of a novel, natural-derived formulation (FPT-20) in supporting spermatogenesis. The investigation focuses on the formulation's potential to reduce inflammatory processes and support tissue regeneration within the testicular lobules, seminiferous tubule epithelium, and surrounding connective tissues. Additionally, the study assesses its ability to restore Leydig and Sertoli cell functions in patients with spermatogenic failure secondary to testicular inflammation.
The group in the trial
- FPT-20 Intervention GroupTreatment being tested
A single-arm group consisting of 16 infertile men with spermatogenic failure secondary to testicular inflammation. All participants receive a standardized therapeutic dose of the natural-derived formulation FPT-20 daily for a duration of 6 to 12 months.
Treatment: FPT-20
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Open-Label Study on the Efficacy of a New Natural Origin Product (FPT-20) in Improving Spermatogenesis and Semen Parameters in Men With Spermatogenic Failure.
- Record updated
- 8 June 2026